LeMaitre Vascular Inc
NASDAQ:LMAT
LeMaitre Vascular Inc
Operating Income
LeMaitre Vascular Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LeMaitre Vascular Inc
NASDAQ:LMAT
|
Operating Income
$37.2m
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
23%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.4B
|
CAGR 3-Years
39%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is LeMaitre Vascular Inc's Operating Income?
Operating Income
37.2m
USD
Based on the financial report for Dec 31, 2023, LeMaitre Vascular Inc's Operating Income amounts to 37.2m USD.
What is LeMaitre Vascular Inc's Operating Income growth rate?
Operating Income CAGR 10Y
23%
Over the last year, the Operating Income growth was 24%. The average annual Operating Income growth rates for LeMaitre Vascular Inc have been 10% over the past three years , 12% over the past five years , and 23% over the past ten years .